Scleroderma Therapeutics Market By Treatment Type (Pharmacological {Immunosuppressants, Endothelin Receptor Antagonists, Phosphodiesterase 5 (PDE5) Inhibitors, Calcium Channel Blockers, Prostacyclin Analogues, Others}, Non-Pharmacological {Physical Therapy, UV-A Phototherapy}, Surgical Interventions {Lung Transplantation, Digital Sympathectomy}), By Disease Type (Localized Scleroderma {Morphea, Linear Scleroderma}, Systemic Scleroderma {Limited Cutaneous Systemic Sclerosis, Diffuse Cutaneous Systemic Sclerosis}), By Route of Administration (Oral, Parenteral, Topical ), By End-User (Hospitals, Clinics, Home Care Settings), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Dec 2024 | Report ID: MI1544 | 225 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Treatment Type

  • Pharmacological
    • Immunosuppressants
    • Endothelin Receptor Antagonists
    • Phosphodiesterase 5 (PDE5) Inhibitors
    • Calcium Channel Blockers
    • Prostacyclin Analogues
    • Others
  • Non-Pharmacological
    • Physical therapy
    • UV-A phototherapy
  • Surgical Interventions
    • Lung transplantation
    • Digital sympathectomy

 By Disease Type

  • Localized Scleroderma
    • Morphea
    • Linear scleroderma
  • Systemic Scleroderma
    • Limited cutaneous systemic sclerosis
    • Diffuse cutaneous systemic sclerosis

By Route of Administration

  • Oral
  • Parenteral
  • Topical

By End-User

  • Hospitals
  • Clinics
  • Home Care Settings

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Boehringer Ingelheim
  • Roche
  • Actelion Pharmaceuticals
  • Bayer AG
  • Pfizer Inc.
  • Bristol-Myers Squibb
  • Gilead Sciences, Inc.
  • Corbus Pharmaceuticals Holdings, Inc.
  • Sanofi
  • Merck & Co., Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Allergan
  • Cytori Therapeutics, Inc.
  • Italfarmaco Group
  • Prometic Life Sciences Inc.
  • Amgen Inc.
  • Kadmon Holdings, Inc.

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing